Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
14
×
life sciences
biotech
boston blog main
fda
clinical trials
san francisco blog main
boston top stories
national top stories
boston
san diego blog main
startups
new york blog main
san diego top stories
san francisco
deals
drugs
san francisco top stories
detroit blog main
detroit top stories
dyne therapeutics
investing
medical device
myotonic dystrophy type 1
new enterprise associates
new york top stories
raleigh-durham blog main
rare disease drugs
san diego
seattle blog main
seattle top stories
texas blog main
texas top stories
achaogen
acute myeloid leukemia
adams street partners
adha
adverum biotechnologies
aimmune therapeutics
akili interactive labs
What
drug
14
×
therapeutics
14
×
medicines
fda
ipo
approved
cancer
million
new
phase
rare
treat
approval
bets
biotech
company
data
developing
disease
dyne
fighting
genetic
latest
medical
medicine
momentum
muscle
raised
therapy
year
adding
affects
agency
ago
aimmune
aldeyra
allergy
americans
announced
athena
Language
unset
Current search:
drug
×
" national blog main "
×
therapeutics
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
Delivery Robots in Big D, Rodriguez Leaves the Station, & More TX Tech
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed